Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells*

Background: MEF2C is an important regulator of many developmental programs. Results: Alternative splicing of the α exon of MEF2C regulates myogenesis. Loss of SRPK3 in rhabdomyosarcoma cells inhibits this splicing and blocks differentiation. Conclusion: MEF2Cα2 promotes myogenesis, and restoration of MEF2Cα2 in rhabdomyosarcoma cells inhibits growth. Significance: Defining the function and deregulation of MEF2Cα2 enhances the understanding of normal myogenesis and RMS tumorigenesis. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Many cellular disruptions contribute to the progression of this pediatric cancer, including aberrant alternative splicing. The MEF2 family of transcription factors regulates many developmental programs, including myogenesis. MEF2 gene transcripts are subject to alternate splicing to generate protein isoforms with divergent functions. We found that MEF2Cα1 was the ubiquitously expressed isoform that exhibited no myogenic activity and that MEF2Cα2, the muscle-specific MEF2C isoform, was required for efficient differentiation. We showed that exon α in MEF2C was aberrantly alternatively spliced in RMS cells, with the ratio of α2/α1 highly down-regulated in RMS cells compared with normal myoblasts. Compared with MEF2Cα2, MEF2Cα1 interacted more strongly with and recruited HDAC5 to myogenic gene promoters to repress muscle-specific genes. Overexpression of the MEF2Cα2 isoform in RMS cells increased myogenic activity and promoted differentiation in RMS cells. We also identified a serine protein kinase, SRPK3, that was down-regulated in RMS cells and found that expression of SRPK3 promoted the splicing of the MEF2Cα2 isoform and induced differentiation. Restoration of either MEF2Cα2 or SPRK3 inhibited both proliferation and anchorage-independent growth of RMS cells. Together, our findings indicate that the alternative splicing of MEF2C plays an important role in normal myogenesis and RMS development. An improved understanding of alternative splicing events in RMS cells will potentially reveal novel therapeutic targets for RMS treatment.

[1]  J. Davie,et al.  TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells , 2014, International journal of cancer.

[2]  A. Krainer,et al.  Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer , 2014, Molecular Cancer Research.

[3]  T. Cooper,et al.  The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. , 2014, Cell reports.

[4]  P. Convertini,et al.  MEF2C exon α: role in gene activation and differentiation. , 2013, Gene.

[5]  J. Davie,et al.  Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells , 2013, Molecular Cancer.

[6]  María Martín,et al.  Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..

[7]  James R. Anderson,et al.  Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. , 2013, Neoplasia.

[8]  C. Keller,et al.  Mechanisms of impaired differentiation in rhabdomyosarcoma , 2013, The FEBS journal.

[9]  Zizhen Yao,et al.  Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation. , 2013, Genes & development.

[10]  Abraham P. Fong,et al.  Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors , 2012, Molecular and Cellular Biology.

[11]  Vassilios Ioannidis,et al.  ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..

[12]  T. Dang,et al.  Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo , 2011, Cell Death and Differentiation.

[13]  J. Davie,et al.  Gamma Interferon Modulates Myogenesis through the Major Histocompatibility Complex Class II Transactivator, CIITA , 2011, Molecular and Cellular Biology.

[14]  J. Davie,et al.  Sequential association of myogenic regulatory factors and E proteins at muscle-specific genes , 2011, Skeletal Muscle.

[15]  K. Baggerly,et al.  Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders , 2010, Muscle & nerve.

[16]  T. Tsukahara,et al.  Alternative splicing of Mef2c promoted by Fox‐1 during neural differentiation in P19 cells , 2010, Genes to cells : devoted to molecular & cellular mechanisms.

[17]  L. Wu,et al.  Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways , 2008, Oncogene.

[18]  A. Aziz,et al.  Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D , 2008, Molecular and Cellular Biology.

[19]  E. Olson,et al.  MEF2: a central regulator of diverse developmental programs , 2007, Development.

[20]  J. Davie,et al.  Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle. , 2007, Developmental biology.

[21]  E. Olson,et al.  Regulation of Skeletal Muscle Sarcomere Integrity and Postnatal Muscle Function by Mef2c , 2007, Molecular and Cellular Biology.

[22]  E. Olson,et al.  Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10 , 2006, Cell.

[23]  M. D'Andrea,et al.  Protein kinase C theta co‐operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells , 2006, Journal of cellular physiology.

[24]  M. Carli,et al.  Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers , 2006, Cancer.

[25]  J. Harper,et al.  A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation , 2006, Science.

[26]  Thomas M. Harris,et al.  Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. , 2005, Genes & development.

[27]  T. Gulick,et al.  Alternative Pre-mRNA Splicing Governs Expression of a Conserved Acidic Transactivation Domain in Myocyte Enhancer Factor 2 Factors of Striated Muscle and Brain* , 2005, Journal of Biological Chemistry.

[28]  F. Barr,et al.  Co‐expression of alternatively spliced forms of PAX3, PAX7, PAX3‐FKHR and PAX7‐FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma , 2005, International journal of cancer.

[29]  S. Tapscott,et al.  A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. , 2004, Genes & development.

[30]  T. Gulick,et al.  Phosphorylation and Alternative Pre-mRNA Splicing Converge To Regulate Myocyte Enhancer Factor 2C Activity , 2004, Molecular and Cellular Biology.

[31]  Wilson Nadruz,et al.  Load-Induced Transcriptional Activation of c-jun in Rat Myocardium: Regulation by Myocyte Enhancer Factor 2 , 2003, Circulation research.

[32]  S. Mohan,et al.  Insulin‐Like Growth Factor I Effect on the Number of Osteoblast Progenitors Is Impaired in Ovariectomized Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[34]  C. Grozinger,et al.  Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4* , 2000, The Journal of Biological Chemistry.

[35]  H. Youn,et al.  Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. , 2000, Immunity.

[36]  Shen-Liang Chen,et al.  The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. , 2000, Genes & development.

[37]  E. Olson,et al.  Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Rudnicki,et al.  Skeletal muscle development in the mouse embryo. , 2000, Histology and histopathology.

[39]  G. Merlino,et al.  Rhabdomyosarcoma – working out the pathways , 1999, Oncogene.

[40]  B. Black,et al.  Activated Notch Inhibits Myogenic Activity of the MADS-Box Transcription Factor Myocyte Enhancer Factor 2C , 1999, Molecular and Cellular Biology.

[41]  E. Dodou,et al.  The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[42]  Jiahuai Han,et al.  Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.

[43]  L. Kedes,et al.  Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.

[44]  E. Olson,et al.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[46]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[47]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[48]  G. Lyons,et al.  Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. , 1994, Development.

[49]  N. Copeland,et al.  A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing , 1994, Molecular and cellular biology.

[50]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[51]  S. Lipton,et al.  hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors , 1993, Molecular and cellular biology.

[52]  J. Biegel,et al.  Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[53]  E. Olson,et al.  MEF2: a calcium-dependent regulator of cell division, differentiation and death. , 2002, Trends in biochemical sciences.

[54]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[55]  David D. McDonald,et al.  Programs , 1984, CL.